The Vendor Drug Program (VDP) will restore the non-preferred status for some branded Concerta Tablets on October 16, 2020, because of sufficient product availability.
The VDP temporarily removed the non-preferred status for brand Concerta products in the Stimulants drug class on April 23, 2020, in response to reported drug shortages. The VDP will reverse this change in status because of sufficient availability in the market. The VDP made this determination after verifying the current availability of the preferred Methylphenidate ER tablet products, and the non-preferred brand Concerta through multiple sources such as the American Society of Health-System Pharmacists, U.S. Food and Drug Administration, manufacturers, wholesalers, and pharmacies in various regions around Texas.
For a complete list of all preferred products in the Stimulants drug class, refer to the July 2020 Preferred Drug List.
|National Drug Code||Drug Name|
|50458058501||Concerta ER 18 MG Tablet|
|50458058801||Concerta ER 27 MG Tablet|
|50458058601||Concerta ER 36 MG Tablet|
|50458058701||Concerta ER 54 MG Tablet|
Contact email@example.com with comments or any questions.